ARTICLES BY DAN SCHELL

  • Lee Clough_510x340
    Do ClinOps Professionals Understand The CAR-T Supply Chain?
    3/4/2024

    Lee Clough RN, HP, of Novartis talks about the importance of understanding the nuances associated with collecting and shipping autologous material (i.e., CAR-Ts) for clinical trials. 

  • Researcher laboratory virus GettyImages-1212345443
    3 Questions On Precigen’s Cell Therapy Studies
    6/13/2023

    Clinical Leader recently touched base with Helen Sabzevari, Ph.D., CEO of Precigen, about the biopharma’s clinical-stage research in the CAR-T therapeutics space. The company currently has six products in its clinical pipeline, including three that use its UltraCAR-T platform.

Dan_2023_4_72DPI

Dan Schell



Dan Schell is Chief Editor of Clinical Leader where he writes about topics related to clinical trial operations. Previously, he served as the Editorial Director of Life Science Leader magazine, another Life Science Connect community, for 14 years. In this role, he worked with the publication’s internal and external writers and editors on choosing the best topics for articles as well as refining all content to meet Life Science Leader’s high editorial standards. Prior to his work with Life Science Leader, he worked as an editor and copy editor for the publication’s parent company, VertMarkets (now called Life Science Connect). He joined the company in 2000 after 10 years of working for Encompass Health (previously Healthsouth) in marketing and business development and four years at an advertising agency.